🇺🇸 FDA
Patent

US 9873893

Methods and compositions for treating genetically linked diseases of the eye

granted A61KA61K38/1709A61K48/00

Quick answer

US patent 9873893 (Methods and compositions for treating genetically linked diseases of the eye) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/1709, A61K48/00, A61K48/0058, A61K9/0046